Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells

Neuroscience Letters

Volumn 346, Issue 3, 2003, Pages 145-148

  Wright, K E ^a   McDonald, J ^a   Barnes, T A ^a   Rowbotham, D J ^a   Guerrini, R ^b   Calo', G ^b   Lambert, D G ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

cAMP formation; GTP 35S binding; Nociceptin receptors; Nociceptin orphanin FQ; Nociceptin orphanin FQ analogues

Indexed keywords

NOCICEPTIN; NOCICEPTIN DERIVATIVE; PARTIAL AGONIST;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CHO CELL; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; INTRINSIC SYMPATHOMIMETIC ACTIVITY; NONHUMAN; PRIORITY JOURNAL;

EID: 0038306210     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00518-4     Document Type: Article

References (21)

1. 2 selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain. J. Pharmacol. Exp. Ther. 294:2000;428-433.
2. Calo G., Guerrini R., Rizzi A., Salvadri S., Regoli D. Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br. J. Pharmacol. 129:2000;1261-1283.
3. 2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor. Br. J. Pharmacol. 136:2002;303-311.
4. 0) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
5. Cox B.M., Chavkin C., Christie M.J., Civelli O., Evans C., Hamon M.D., Hoellt V., Kieffer B., Kitchen I., McKnight A.T., Meunier J.C., Portoghese P.S. Opioid receptors. Girdlestone D. The IUPHAR Compendium of Receptor Characterization and Classification. 2000;321-333 IUPHAR Media, London.
6. Guerrini R., Calo G., Rizzi A., Bigoni R., Bianchi C., Salvadori S., Regoli D. A new selective antagonist of the nociceptin receptor. Br. J. Pharmacol. 123:1998;163-165.
7. 2 peptide bond. Bioorg. Med. Chem. Lett. 13:2003;365-368.
8. Hashiba E., Harrison C., Galo G., Guerrini R., Rowbotham D.J., Smith G., Lambert D.G. Characterisation and comparison of novel ligands for the nociceptin/orphanin FQ receptor. Naunyn-Schmiedeberg's Arch. Pharmacol. 363:2001;28-33.
9. Hashiba E., Lambert D.G., Jenck F., Wichmann J., Smith G. Characterisation of the non-peptide nociceptin receptor agonist, Ro64-6198, in Chinese hamster ovary cells expressing recombinant human nociceptin receptors. Life Sci. 70:2002;1719-1725.
10. 2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats. J. Pharmacol. Exp. Ther. 289:1999;173-180.
11. Kenakin T. Drug efficacy at G protein-coupled receptors. Annu. Rev. Pharmacol. Toxicol. 42:2002;349-379.
12. 2 at rat native and recombinant ORL(1) receptors. Neuropeptides. 35:2001;244-256.
13. 35S binding and cAMP formation in Chinese hamster ovary cells expressing the human nociceptin/orphanin FQ receptor. Eur. J. Pharmacol. 443:2002;7-12.
14. 2 at the recombinant human nociceptin receptor using the ecdysone inducible expression system, British Pharmacological Society (Abstract, Brighton Meeting, 2003), CO26.
15. Meunier J., Mouledous L., Topham C.M. The nociceptin (ORL1) receptor: molecular cloning and functional architecture. Peptides. 21:2000;893-900.
16. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.L., Guillemot J.C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Permentier M., Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
17. Mogil J.S., Pasternak G.W. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol. Rev. 53:2001;381-415.
18. 2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors. Br. J. Pharmacol. 127:1999;123-130.
19. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J. Jr., Civelli O. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science. 270:1995;792-794.
20. Toll L., Burnside J., Berzetei-Gurske I.P. Agonist Activity of ORL1 Antagonists is Dependent Upon Receptor Number. 1998;INRC, Garmisch-Partenkirchen.
21. 2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cord. Neurosci. Lett. 249:1998;127-130.